Clinigen Group plc operates as a specialty pharmaceutical and services company. The company operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines in the Africa and Asia Pacific region.
Read More…
Industry, Sector and Symbol
Industry Drug Delivery
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-1283-495010
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£456.90 million
Profitability
Miscellaneous
Employees849
Next Earnings DateN/A
OptionableNot Optionable
Clinigen Group (LON:CLIN) Frequently Asked Questions
What is Clinigen Group's stock symbol?
Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."
How often does Clinigen Group pay dividends? What is the dividend yield for Clinigen Group?
Clinigen Group announced a dividend on Thursday, September 19th. Shareholders of record on Thursday, November 7th will be paid a dividend of GBX 4.75 per share on Friday, November 29th. This represents a yield of 0.51%. The ex-dividend date of this dividend is Thursday, November 7th. This is a boost from Clinigen Group's previous dividend of $1.95. The official announcement can be accessed at this link. View Clinigen Group's Dividend History.
How were Clinigen Group's earnings last quarter?
Clinigen Group PLC (LON:CLIN) issued its quarterly earnings results on Tuesday, February, 27th. The company reported $21.20 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $20.30 by $0.90. The firm earned $167.80 million during the quarter. View Clinigen Group's Earnings History.
What price target have analysts set for CLIN?
5 equities research analysts have issued 12 month target prices for Clinigen Group's shares. Their predictions range from GBX 1,000 to GBX 1,640. On average, they expect Clinigen Group's stock price to reach GBX 1,295 in the next twelve months. This suggests a possible upside of 62.0% from the stock's current price. View Analyst Price Targets for Clinigen Group.
What is the consensus analysts' recommendation for Clinigen Group?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Clinigen Group.
Has Clinigen Group been receiving favorable news coverage?
News headlines about CLIN stock have trended somewhat positive on Monday, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Clinigen Group earned a news sentiment score of 0.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Clinigen Group.
Who are some of Clinigen Group's key competitors?
Some companies that are related to Clinigen Group include Premier (PINC), Repligen (RGEN), Healthequity (HQY), Spark Therapeutics (ONCE), BTG (BTGGF), Cronos Group (CRON), Ablynx (ABLYF), Aurora Cannabis (ACB), GETINGE AB/ADR (GNGBY), Tandem Diabetes Care (TNDM), GW Pharmaceuticals PLC- (GWPH), Blueprint Medicines (BPMC), LHC Group (LHCG), Ansell (ANN) and SmileDirectClub (SDC).
What other stocks do shareholders of Clinigen Group own?
Who are Clinigen Group's key executives?
Clinigen Group's management team includes the folowing people:
- Mr. Shaun Edward Chilton, CEO & Exec. Director (Age 51)
- Mr. Nicholas Keher, CFO & Director
- Ms. Debra Ainge, Chief Operating Officer
- Matt Parrish, Head of Investor Relations
- Mr. David Bryant, Director of Corp. Devel.
How do I buy shares of Clinigen Group?
Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Clinigen Group's stock price today?
One share of CLIN stock can currently be purchased for approximately GBX 799.50.
How big of a company is Clinigen Group?
What is Clinigen Group's official website?
How can I contact Clinigen Group?
Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.
MarketBeat Community Rating for Clinigen Group (LON CLIN)
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe CLIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLIN will underperform the S&P 500 over the long term. You may vote once every thirty days.
